v3.26.3
Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]    
Total operating earnings $ 753 $ 668
Cost of Product and Service Sold 64,917 61,690
Selling, General and Administrative Expense 1,595 1,461
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 688 598
Operating Segments    
Segment Reporting [Line Items]    
Total operating earnings 1,009 879
Cost of Product and Service Sold 64,940 61,711
Selling, General and Administrative Expense 1,587 1,440
Costs and Expenses 66,527 63,151
Operating Segments | Pharmaceutical and Specialty Solutions    
Segment Reporting [Line Items]    
Total operating earnings 783 667
Cost of Product and Service Sold 61,001 57,857
Selling, General and Administrative Expense 798 681
Costs and Expenses 61,799 58,538
Operating Segments | GMPD    
Segment Reporting [Line Items]    
Total operating earnings 33 46
Cost of Product and Service Sold 2,636 2,633
Selling, General and Administrative Expense 521 505
Costs and Expenses 3,157 3,138
Operating Segments | Other Operating Segment    
Segment Reporting [Line Items]    
Total operating earnings 193 166
Cost of Product and Service Sold 1,303 1,221
Selling, General and Administrative Expense 268 254
Costs and Expenses 1,571 1,475
Corporate    
Segment Reporting [Line Items]    
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $ (321) $ (281)